What are the best treatments for Congenital Nephrotic Syndrome Finnish Type?

Congenital Nephrotic Syndrome Finnish Type (CNF) is a rare genetic disorder characterized by massive proteinuria beginning in utero or shortly after birth. The primary treatment strategy involves aggressive supportive care—including albumin infusions and nutritional support—followed by early unilateral nephrectomy and eventual kidney transplantation, which remains the definitive cure for Congenital Nephrotic Syndrome Finnish Type.

How is Congenital Nephrotic Syndrome Finnish Type managed medically?

Because the glomerular filtration barrier defect in Congenital Nephrotic Syndrome Finnish Type is resistant to standard steroid and immunosuppressive therapies, focus is placed on managing complications. Supportive care typically includes:

• Frequent intravenous albumin infusions to manage hypoalbuminemia and edema.


• High-caloric, protein-rich diets, often requiring nasogastric tube feeding to ensure adequate growth.


• Thyroxine replacement to treat losses of thyroid-binding globulins.


• Prophylactic anticoagulation and antibiotic therapy to mitigate the high risk of thrombosis and infections associated with Congenital Nephrotic Syndrome Finnish Type.

What surgical interventions are required?

Due to the severity of protein loss, most infants with Congenital Nephrotic Syndrome Finnish Type eventually require a unilateral nephrectomy to reduce proteinuria, followed by peritoneal dialysis until the child reaches the weight and maturity necessary for a kidney transplant. Transplantation typically occurs once the patient reaches approximately 8–10 kilograms, offering a near-complete resolution of the nephrotic symptoms.

Which specialists should be on the care team?

Managing Congenital Nephrotic Syndrome Finnish Type requires a highly coordinated multidisciplinary team. Essential members include pediatric nephrologists, transplant surgeons, pediatric nutritionists, and clinical geneticists. As our community of 4 members at DiseaseMaps.org highlights, the journey is complex, making the support of social workers and clinical psychologists specializing in chronic pediatric illness vital for families navigating this diagnosis.

What is the outlook for patients?

While Congenital Nephrotic Syndrome Finnish Type is a life-altering diagnosis, long-term outcomes for patients following a successful kidney transplant are generally excellent. Treatment effectiveness varies significantly based on the timing of nutritional intervention and the prevention of early-life complications like sepsis or venous thrombosis.

Next steps

• Consult with a pediatric nephrology center experienced in managing rare glomerular diseases.


• Coordinate with a genetic counselor to discuss the 25% recurrence risk for future pregnancies.


• Connect with the DiseaseMaps.org community to share experiences with other families affected by this condition.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice; all treatment plans for Congenital Nephrotic Syndrome Finnish Type must be personalized by your specialized medical team.

References

• Orphanet: Congenital nephrotic syndrome of the Finnish type (ORPHA:650)


• NIH GARD: Congenital nephrotic syndrome, Finnish type


• OMIM: Nephrotic Syndrome, Congenital, Finnish Type (NPHS1)